These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8022862)

  • 1. Empirical and rational approaches for development of inhibitors of the human immunodeficiency virus--HIV-1.
    Prusoff W; Lin TS; Pivazyan A; Sun AS; Birks E
    Pharmacol Ther; 1993 Nov; 60(2):315-29. PubMed ID: 8022862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2'-5'-bis-O-(tert-butyldimethylsilyl)-beta-D-xylo- and -ribofuranose]-3'-spiro-5"-[4"-amino-1",2"-oxathiole 2",2"-dioxide] (TSAO) pyrimidine nucleosides.
    Camarasa MJ; Pérez-Pérez MJ; San-Félix A; Balzarini J; De Clercq E
    J Med Chem; 1992 Jul; 35(15):2721-7. PubMed ID: 1495006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 6-azapyrimidine-2'-deoxy-4'-thionucleosides: synthesis, biological evaluation and conformational analysis.
    Inguaggiato G; Hughes D; De Clercq E; Balzarini J; Simons C
    Antivir Chem Chemother; 1999 Sep; 10(5):241-9. PubMed ID: 10574179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified oligopeptides designed to interact with the HIV-1 proteinase inhibit viral replication.
    Grinde B; Hungnes O; Tjøtta E
    Arch Virol; 1990; 114(3-4):167-73. PubMed ID: 2241573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
    Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
    J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel 6-azapyrimidine acyclic nucleoside analogues and antiviral evaluation.
    Jasamai M; Simons C; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2010 Jul; 29(7):535-41. PubMed ID: 20589572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of [(2'S, 3'S)-bis(hydroxylmethyl)pyrrolidin-1-yl] purine and pyrimidine nucleosides as potential antiviral agents.
    Oohashi T; Nishiyama S; Yamamura S; Kato K
    Bioorg Med Chem Lett; 1998 May; 8(10):1187-8. PubMed ID: 9871732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol.
    Royer RE; Mills RG; Deck LM; Mertz GJ; Vander Jagt DL
    Pharmacol Res; 1991 Dec; 24(4):407-12. PubMed ID: 1805194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds.
    Royer RE; Deck LM; Vander Jagt TJ; Martinez FJ; Mills RG; Young SA; Vander Jagt DL
    J Med Chem; 1995 Jun; 38(13):2427-32. PubMed ID: 7608907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationships (QSARs) of pyrimidine nucleosides as HIV-1 antiviral agents.
    Mahmoudian M
    Pharm Res; 1991 Jan; 8(1):43-6. PubMed ID: 2014207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity.
    Kim HO; Ahn SK; Alves AJ; Beach JW; Jeong LS; Choi BG; Van Roey P; Schinazi RF; Chu CK
    J Med Chem; 1992 May; 35(11):1987-95. PubMed ID: 1597854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV).
    Lin TS; Guo JY; Schinazi RF; Chu CK; Xiang JN; Prusoff WH
    J Med Chem; 1988 Feb; 31(2):336-40. PubMed ID: 3339606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosides and nucleotides. 185. Synthesis and biological activities of 4'alpha-C-branched-chain sugar pyrimidine nucleosides.
    Nomura M; Shuto S; Tanaka M; Sasaki T; Mori S; Shigeta S; Matsuda A
    J Med Chem; 1999 Jul; 42(15):2901-8. PubMed ID: 10425099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis and antiviral activity of D-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides.
    Chong Y; Choo H; Choi Y; Mathew J; Schinazi RF; Chu CK
    J Med Chem; 2002 Oct; 45(22):4888-98. PubMed ID: 12383014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol.
    Lin TS; Schinazi RF; Zhu J; Birks E; Carbone R; Si Y; Wu K; Huang L; Prusoff WH
    Biochem Pharmacol; 1993 Jul; 46(2):251-5. PubMed ID: 8347147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    McQuade TJ; Tomasselli AG; Liu L; Karacostas V; Moss B; Sawyer TK; Heinrikson RL; Tarpley WG
    Science; 1990 Jan; 247(4941):454-6. PubMed ID: 2405486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.
    Jeong LS; Schinazi RF; Beach JW; Kim HO; Nampalli S; Shanmuganathan K; Alves AJ; McMillan A; Chu CK; Mathis R
    J Med Chem; 1993 Jan; 36(2):181-95. PubMed ID: 8423591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.